Abstract
Background: There have been mixed findings on whether mortality is socially patterned among people with diabetes. We compared all-cause mortality trends by socioeconomic position (SEP) among people with and without diabetes for 2004-2021 in four high-income countries. Methods: We conducted open cohort studies in Australia, Denmark, the Netherlands, and Scotland and included national or regional populations aged 35-69 years. We used the European standard population in 2013 to calculate age-standardised mortality rates (ASMRs) by calendar year, SEP quintile, diabetes status, and sex. SEP quintiles were defined using standardised disposable household income in Denmark and the Netherlands, and area-based indices in Australia and Scotland. We calculated the age-standardised slope index of inequality (SII) and age-adjusted relative index of inequality (RII) using Poisson regression as absolute and relative measures of socioeconomic inequality respectively across the study populations stratified by calendar year, diabetes status, and sex. Results: 208,011 deaths occurred during 17 million person years (py) of follow-up among 35-69 year olds with diabetes, and 1.1 million deaths during 298 million py of follow-up among people without diabetes. ASMRs generally increased with increasing deprivation and varied between 1.3 (95% CI: 1.2-1.4) deaths per 1000 py to 29.4 (95% CI: 26.0-32.8) deaths per 1000 py. We found absolute and relative mortality inequality among those with and without diabetes, both generally increased during the follow-up period. Conclusion: Disparities in mortality by SEP increased during follow-up in most countries. Strategies are needed to reduce excess mortality associated with low SEP and diabetes and related socioeconomic inequality.
Competing Interest Statement
Outside of the submitted work, HS received personal fees for statistical consulting from Novartis, Pfizer, MSD (Merck Sharpe & Dohme), Neumirna and Vesper Bio Aps. The remaining authors declare no competing interests.
Funding Statement
DJM is supported by National Health and Medical Research Council (NHMRC) Investigator Fellowship L2. HS, TL, SBG and ER were supported by Steno Diabetes Center Aarhus, which is partially funded by an unrestricted donation from the Novo Nordisk Foundation. The funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical Ethical Review Board of Leiden University Medical Center waived ethical approval for this work (non-WMO approval number: 24-3010).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.